Cargando…
A multicenter, open-label, noninterventional study to evaluate the impact on clinical effects, user-friendliness and patients’ acceptance of AirFluSal Forspiro in the treatment of asthma under real-life conditions (ASSURE)
Background: The design of inhaler devices may potentially influence adherence/persistence and outcomes in asthma. Objective: The primary objective was to assess asthma control and any change in the quality of life in patients using an intuitive dry powder inhaler containing fluticasone propionate/sa...
Autores principales: | Backer, Vibeke, Bjermer, Leif, Refvem, Olav Kåre, Søderman, Andreas, Jones, Spencer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541794/ https://www.ncbi.nlm.nih.gov/pubmed/31213944 http://dx.doi.org/10.2147/POR.S200654 |
Ejemplares similares
-
Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma
por: van Zyl-Smit, Richard N, et al.
Publicado: (2023) -
Clinical and daily respiratory care and clinical trials within the COVID-19 era
por: Diamant, Zuzana, et al.
Publicado: (2020) -
The launch of the European Clinical Respiratory Journal, the scientific forum of the Nordic Respiratory Academy
por: Bjermer, Leif, et al.
Publicado: (2014) -
How is the organisational settings, content and availability of comprehensive multidisciplinary pulmonary rehabilitation for people with COPD in primary healthcare in Norway: a cross-sectional study
por: Frisk, Bente, et al.
Publicado: (2022) -
Overcoming Old in Age-Friendliness
por: Lindenberg, J., et al.
Publicado: (2015)